425 related articles for article (PubMed ID: 9708542)
1. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
2. Conduction block in acute motor axonal neuropathy.
Kokubun N; Nishibayashi M; Uncini A; Odaka M; Hirata K; Yuki N
Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
[TBL] [Abstract][Full Text] [Related]
3. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
5. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
7. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
8. The clinical correlates of high-titer IgG anti-GM1 antibodies.
Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
[TBL] [Abstract][Full Text] [Related]
9. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
Yuki N; Kuwabara S
J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
[TBL] [Abstract][Full Text] [Related]
10. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
Yuki N; Yoshino H; Sato S; Shinozawa K; Miyatake T
Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
[TBL] [Abstract][Full Text] [Related]
11. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
Kuwabara S; Bostock H; Ogawara K; Sung JY; Kanai K; Mori M; Hattori T; Burke D
Muscle Nerve; 2003 Dec; 28(6):683-9. PubMed ID: 14639581
[TBL] [Abstract][Full Text] [Related]
12. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
13. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
Harvey GK; Toyka KV; Zielasek J; Kiefer R; Simonis C; Hartung HP
Muscle Nerve; 1995 Apr; 18(4):388-94. PubMed ID: 7715623
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
Bae JS; Kim BJ
J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
[TBL] [Abstract][Full Text] [Related]
16. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
17. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
Rajabally YA; Hassan-Smith G; Notturno F; Eames PJ; Hayton T; Capasso M; Uncini A
J Neurol Sci; 2011 Apr; 303(1-2):35-8. PubMed ID: 21316711
[TBL] [Abstract][Full Text] [Related]
18. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
19. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H
Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788
[TBL] [Abstract][Full Text] [Related]
20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
